Delivery Order SPE2DB20D3101-SPE2DB25FRHW5

Award Date 4/27/25
Potential Completion Date 4/28/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUYD4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has a ceiling value of $7,730.78 and is a delivery order for the supply of 4,567,941,136 units of Cetirizine HCl 10 mg tablets. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen Drug Corp also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, with ID SPE2DB22D1002|SPE2DB25FKXQ8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,145,587 units of Cetirizine HCL 10 mg tablets in 100-count packages, with a ceiling value of $1,056.33. This is a firm-fixed-price delivery order contract with a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FE9AY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $5,738.30, is a Delivery Order for the supply of 4,566,420,169 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This contract is not designated...
This federal contract award is a delivery order (SPE2DB20D3101|SPE2DB24FRTJ5) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.56 firm fixed price contract is for the delivery of 4,565,618,723 units of Cetirizine HCL 5 mg tablets, which are used to treat various medical conditions. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.20 firm fixed-price delivery order is for the supply of 4,567,268,086 units of Cetirizine HCL 10 mg tablets, a generic antihistamine medication. The contract has an ultimate completion date of February 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.90, is a delivery order for the supply of Cetirizine HCL 10 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,850.14 firm fixed-price delivery order is for the supply of 4567669461 - Cetirizine HCL 10 mg Tablets, 500 count. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,117.74 and an ultimate completion date of April 16, 2025. The award is for the delivery of 4,567,922,388 units of the pharmaceutical product Cetirizine HCL 5 mg tablets in 100-count packaging. This contract is not set aside and is considered an open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRHW5
    Delivery Order

This federal contract award, identified as SPE2DB20D3101|SPE2DB25FRHW5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,271.88 firm fixed-price delivery order is for the supply of 4,568,044,739 units of Cetirizine HCl 5 mg tablets. The contract has an ultimate completion date of April 28, 2025 and is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/27/25, 11:08 AM